LVOOX
Price
$20.65
Change
+$0.06 (+0.29%)
Updated
Sep 5 closing price
Net Assets
1.14B
VIMAX
Price
$358.38
Change
-$0.51 (-0.14%)
Updated
Sep 5 closing price
Net Assets
199.16B
Interact to see
Advertisement

LVOOX vs VIMAX

Header iconLVOOX vs VIMAX Comparison
Open Charts LVOOX vs VIMAXBanner chart's image
Lord Abbett Value Opportunities F3
Price$20.65
Change+$0.06 (+0.29%)
VolumeN/A
Net Assets1.14B
Vanguard Mid Cap Index Admiral
Price$358.38
Change-$0.51 (-0.14%)
VolumeN/A
Net Assets199.16B
LVOOX vs VIMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LVOOX vs. VIMAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVOOX is a Buy and VIMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 199B vs. LVOOX (1.14B). VIMAX pays higher dividends than LVOOX: VIMAX (1.47) vs LVOOX (0.20). LVOOX was incepted earlier than VIMAX: LVOOX (8 years) vs VIMAX (24 years). LVOOX (0.84) is less costly to investors than VIMAX (0.05). LVOOX is a more actively managed with annual turnover of: 33.00 vs. VIMAX (16.00). LVOOX has a lower initial minimum investment than VIMAX: LVOOX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 15.04 vs. LVOOX (-1.01). VIMAX return over 5 years is better than : 65.04 vs. LVOOX (17.05).
LVOOXVIMAXLVOOX / VIMAX
Total Expense Ratio0.840.051,680%
Annual Report Gross Expense Ratio0.840.051,680%
Fund Existence8 years24 years-
Gain YTD0.8309.7099%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B199B1%
Annual Yield % from dividends0.201.4714%
Returns for 1 year-1.0115.04-7%
Returns for 3 years14.8541.0736%
Returns for 5 years17.0565.0426%
Returns for 10 yearsN/A141.10-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGBPP0.04N/A
+0.50%
Regen Biopharma, Inc.
TSRUF7.24N/A
N/A
Pacific Current Group Ltd.
ZEOOF9.35N/A
N/A
Zeon Corp.
MEDIF0.05N/A
-1.26%
Medipharm Labs Corporation
MTHRY7.70-0.11
-1.41%
M3, Inc.